Your session is about to expire
← Back to Search
Caffeine - Phase 2 for Healthy Subjects
Study Summary
This trial is looking at how caffeine affects different biomarkers in the blood that may be related to cardiovascular disease. Researchers will give participants either a placebo or 400mg of caffeine in pill form and collect
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the inclusion criteria for this trial limited to individuals who have reached adulthood, specifically 18 years or older?
"Individuals aged 18 to below 80 are eligible for enrollment in this research project."
Which individuals meet the criteria to be considered for inclusion in this research study?
"To be eligible for enrollment in this research study, potential participants must be individuals without known medical conditions and aged between 18 to 80 years. The trial aims to recruit approximately 36 subjects."
Are eligible patients able to enroll in this ongoing trial at the present time?
"As per the details on clinicaltrials.gov, this specific research investigation is presently not in need of additional participants. Although it was initially shared on 4/8/2024 and last revised on 4/5/2024, there are currently 1334 alternative studies actively seeking eligible candidates for participation."
Share this study with friends
Copy Link
Messenger